M Bhushan, K McElhone, C E Griffiths. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acetylmuramyl-Alanyl-Isoglutamine/adverse effectsAcetylmuramyl-Alanyl-Isoglutamine/analogs & derivativesAdjuvants, Immunologic/adverse effectsAnalysis of VarianceChronic DiseaseHumansPsoriasis/drug therapyTreatment Failure
Substances： See more » Adjuvants, ImmunologicAcetylmuramyl-Alanyl-Isoglutamineglucosaminylmuramyl-2-alanine-D-isoglutamine
Year: 1998 PMID： 9851410 DOI： 10.1016/S0140-6736(05)79923-2
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321